SECTION 2. HAZARDS IDENTIFICATION

CLASSIFICATION OF SUBSTANCE OR MIXTURE

Pictogram
Signal Word Warning
Hazard Statements
H302+H312+H332 Harmful if swallowed, in contact with skin, or if inhaled.
Precautionary Phrases
P261 Avoid breathing dust/fume/gas/mist/vapors/spray.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor/physician if you feel unwell.
HMIS CLASSIFICATION:
Health: 2 Fire: 0 Reactivity Hazard: 1
NFPA RATING:
Health: 2 Flammability: 0 Reactivity Hazard: 1
EYE CONTACT: Causes irritation of the eyes.
SKIN CONTACT: Harmful in contact with skin.
INHALATION: Harmful if inhaled.
INGESTION: Harmful if swallowed.

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

Formula: CdSb
Molecular Weight: 234.16
CHEMICAL NAME CAS# %
Cadmium Antimonide 12050-27-0 100

SECTION 4. FIRST AID MEASURES

EYE EXPOSURE: Immediately flush the eyes with copious amounts of water for at least 15 minutes. Assure flushing under
eyelids. A victim may need assistance in keeping their eyelids open. Get immediate competent medical attention.
SKIN EXPOSURE: Wash affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
irritation persists.
INHALATION: Remove to fresh air and keep at rest. Closely monitor the victim for signs of respiratory problems, such as
difficulty in breathing, coughing, wheezing, or pain. In such cases, seek immediate medical assistance.
INGESTION: Seek medical attention immediately.

SECTION 5. FIREFIGHTING MEASURES

FLASH POINT: Product is not flammable.
Autoignition: Not available
EXPLOSION LIMITS: This product does not present an explosion hazard.
EXTINGUISHING MEDIUM: Use fire fighting measures that suit the surrounding fire.
SPECIAL FIRE FIGHTING PROCEDURES: Wear self-contained, approved breathing apparatus and full protective clothing,
including eye protection and boots.
HAZARDOUS COMBUSTION AND DECOMPOSITION PRODUCTS: Cadmium oxide and antimony oxide.

SECTION 6. ACCIDENTAL RELEASE MEASURES

PERSONAL PRECAUTIONS: Wear all appropriate equipment when using this material. Ensure adequate ventilation. Keep unprotected
persons away.
ENVIRONMENTAL PRECAUTIONS: Prevent spillage from entering drains or allowing to be released into the environment.
METHODS AND MATERIALS FOR CONTAINMENT AND CLEANING UP: Pick up and arrange disposal without creating dust. Sweep
up and keep in suitable, closed containers for disposal.

SECTION 7. HANDLING AND STORAGE

PRECAUTIONS FOR SAFE HANDLING: Wear appropriate personal protective equipment. Use with adequate ventilation. Avoid
contact with skin and eyes. Avoid formation of dust.
CONDITIONS FOR SAFE STORAGE: Store in cool, dry, and well-ventilated area. Store away from oxidizing agents.

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

EXPOSURE CONTROLS:
Component Exposure Limits Basis Entity
Cadmium Antimonide 0.5 mg/m3 TLV ACGIH
0.5 mg/m3 PEL OSHA
0.002 mg/m3 TLV ACGIH
0.002 mg/m3 PEL OSHA
PEL: Permissible Exposure Limit TLV: Threshold Limit Value over 8 hours of work.
EYE PROTECTION: Wear chemical safety glasses or goggles and face shield.
SKIN PROTECTION: Wear nitrile or rubber gloves, apron, or lab coat.
VENTILATION: Provide local exhaust, preferably mechanical.
RESPIRATOR: Use an approved respirator.
ADDITIONAL PROTECTION: Provide eyewash stations, quick-drench showers and washing facilities accessible to areas of use and
handling.

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

COLOR AND FORM: Black solid
ODOR: None
MOLECULAR WEIGHT: 234.16
BOILING POINT: No data available
MELTING POINT: Not available
SPECIFIC GRAVITY: 6.92 gm/ml
VAPOR DENSITY: No data available
SOLUBILITY: Insoluble

SECTION 10. STABILITY AND REACTIVITY

STABILITY: Stable
HAZARDOUS POLYMERIZATION: Will not occur
CONDITIONS TO AVOID: None known
INCOMPATIBILITY: Strong oxidizing agents
DECOMPOSITION PRODUCTS: Cadmium oxide and antimony oxide

SECTION 11. TOXICOLOGICAL INFORMATION

ACUTE TOXICITY: Not available
CARCINOGENIC EFFECTS: Carcinogenic to humans.
MUTAGENIC EFFECTS: Not available
TETRATOGENIC EFFECTS: Not available
RTECS: Not available
Antimony compounds may cause metallic taste, gastrointestinal disturbances, vomiting, diarrhea, dizziness, and systemic poisoning.
Chronic exposure may cause liver and kidney damage. Dermatitis and eczematous skin eruptions may result from skin contact.
Cadmium compounds are highly toxic and experimental carcinogens. Exposure affects the respiratory tract, kidneys, and liver.
Ingestion may cause nausea, salivation, vomiting, and diarrhea. Ingestion or inhalation of cadmium compounds may be fatal.
To the best of our knowledge the toxicological effects of this compound have not been fully investigated.

SECTION 12. ECOLOGICAL INFORMATION

Very toxic for aquatic organisms. May cause long lasting harmful effects to aquatic life. Also poisonous for fish and plankton in water
bodies. Danger to drinking water if even extremely small quantities leak into the ground.

SECTION 13. DISPOSAL CONSIDERATIONS

Dispose of in according to local, state, and federal regulations.

SECTION 14. TRANSPORT INFORMATION

UN2570 UN2570
Cadmium compounds, n.o.s. Cadmium compound, n.o.s.
(cadmium antimonide) (cadmium antimonide)
Class 6.1 Class 6.1
PG III PG III
Marine Pollutant: No

SECTION 15. REGULATORY INFORMATION

SARA (TITLE 313): Cadmium antimonide
CALIFORNIA PROP. 65: Cadmium antimonide